Viewing StudyNCT00477282



Ignite Creation Date: 2024-05-05 @ 5:31 PM
Last Modification Date: 2024-10-26 @ 9:33 AM
Study NCT ID: NCT00477282
Status: COMPLETED
Last Update Posted: 2020-03-12
First Post: 2007-05-21

Brief Title: Karenitecin Versus Topotecan in Patients With Advanced Epithelial Ovarian Cancer
Sponsor: BioNumerik Pharmaceuticals Inc
Organization: BioNumerik Pharmaceuticals Inc

Conditions & Keywords Data

Conditions:
Name
Ovarian Cancer
Keywords:
Name View
Advanced Ovarian Cancer View
Ovarian View
Cancer View